About Tech Council Ventures
Tech Council Ventures is a venture capital firm founded in 2000. It is primarily based out of Summit, United States. As of Feb 2026, Tech Council Ventures is an active investor, having invested in 45 companies, with 2 new investments in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Life Sciences and HealthTech. Most recently it participated in the $***** Seed round of PolyGone Overall, Tech Council Ventures portfolio has seen 1 IPO and 18 acquisitions including key companies like Intra-Cellular Therapies, Nuance and IntegriChain. A lot of funds co-invest with Tech Council Ventures, with names like Boston Millennia Partners sharing a substantial percentage of its portfolio. Tech Council Ventures has team of 7 people including 4 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Seed & 1 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns
Deals in last 12 months
Tech Council Ventures' List of Top Investments
Tech Council Ventures has a portfolio of 45 companies. Their most notable investments are in CatherineGives and ChoiceWorx.Their portfolio spans across United States, Australia, Israel and 1 more locations. They have invested in Enterprise Applications, Life Sciences, HealthTech and 19 other sectors, across stages such as Series A, Seed and 1 more. Here is the list of top investments by Tech Council Ventures:Developer of therapeutics for psychiatric and neurologic diseases. The company’s product, ITI-007 is a novel first-in-class 5-HT2A antagonist, Dopamine receptor phosphoprotein modulator (DPPM) designed to treat multiple deficits in patients with schizophrenia while lacking the side-effects of existing antipsychotic drugs. It also developed a state of the art technology platform, called CNSProfil that is capable of generating a unique molecular signature for drug compounds.
Key facts about Intra-Cellular Therapies
- Founded Year: 2002
- Location: New York City (United States)
- Annual Revenue: $681M as on Dec 31, 2024
- Stage: Acquired
- Total Funding till date: $80.9M
- Employee Count: 835 as on Jan 31, 2026
- Investors: BB Biotech, International Biotechnology Trust and 6 Others
- Latest Funding Round: Grant (prize money), Jul 01, 2014, $*****
- Highlight: Acquired
2. Nuance
Conversational AI solutions for enterprises. It provides digital, voice, and messaging solutions that helps to optimize the customer experiences. Features include IVR, analytics, contact center solutions, and more. It caters its solution to industries such as healthcare, telecommunications, automotive, financial services, and retail.
Key facts about Nuance
- Founded Year: 1992
- Location: London (United Kingdom)
- Annual Revenue: $1.36B as on Sep 30, 2021
- Stage: Acquired
- Total Funding till date: $15.6M
- Employee Count: 3,938 as on Jan 31, 2026
- Investors: Intel, Goldman Sachs and 19 Others
- Latest Funding Round: Post IPO, May 28, 2021, $*****
- Highlight: Acquired
3. IntegriChain
Pharma commercialization solutions: data, consulting, and technology for market access. The company offers a comprehensive suite of services and a platform designed to address the complexities of drug commercialization. It provides strategy, data, applications, and infrastructure for therapy commercialization, focusing on optimizing price and demand through integrated commercial and net revenue analytics. The company delivers solutions for net revenue management, commercial data, and insights, helping pharmaceutical manufacturers bring their science to market. Its offerings include consulting and advisory services, regulatory compliance, market access strategy, and data and technology solutions. The company empowers pharma companies to build efficient access, affordability, and distribution strategies, maximizing net revenue. It unifies critical business functions like contracts & pricing, gross-to-net, channel, and patient services to unlock strategic insights. The platform supports data visualization, AI enablement, and data management services. It is a B2B company offering SaaS and software solutions.
Key facts about IntegriChain
- Founded Year: 2005
- Location: Philadelphia (United States)
- Stage: Acquired
- Total Funding till date: $2M
- Employee Count: 320 as on Dec 31, 2022
- Investors: SaaS Capital, Activate Venture Partners and 4 Others
- Latest Funding Round: PE, Mar 01, 2016, $*****
- Highlight: Acquired
Transforming cancer care through real-world data and insights. They empower oncology research, regulatory, commercial, and HEOR teams with detailed real-world patient data to discover new treatment protocols and transform cancer care. They offer curated databases of oncology patient data, analytics solutions, and expert clinical insights to expedite timelines, support regulatory submissions, validate commercial strategies, and carry out post-marketing studies. Their services help oncology practices and cancer centers make sense of fragmented EHR data. They provide high-quality cancer real-world data and insights, including longitudinal real-world outcomes datasets curated to specific cancer types and subpopulations. They leverage technology-driven curation with deep oncology expertise to provide credible, complete, and clinically meaningful data. They are focused on building datasets with a specific use case in mind, supporting external control arms, uncovering treatment patterns, and informing regulatory-grade evidence.
Key facts about Cota Healthcare
- Founded Year: 2013
- Location: New York City (United States)
- Stage: Series D
- Total Funding till date: $103M
- Employee Count: 240 as on Jan 31, 2026
- Investors: Deerfield, Celgene and 13 Others
- Latest Funding Round: Series D, Oct 25, 2022, $*****
- Highlight: Editors' Pick
5. Cytosorbents
Developer of hemoperfusion technology for removing toxins from the blood. It develops and manufactures therapeutic devices that purify the blood. Its purification technology is based on biocompatible, porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Each polymer bead contains millions of pores and channels that can be modified to remove substances as small as drugs, to substances as large as antibodies.
Key facts about Cytosorbents
- Founded Year: 1997
- Location: Monmouth Junction (United States)
- Annual Revenue: $35.6M as on Dec 31, 2024
- Stage: Public
- Total Funding till date: $22M
- Employee Count: 198 as on Dec 31, 2022
- Investors: Western Alliance Bank, National Heart Lung and Blood Institute and 4 Others
- Latest Funding Round: Grant (prize money), Sep 01, 2022, $*****
- Highlight: Public
Tech Council Ventures' Year-on-Year Investment Trends
Tech Council Ventures has invested in 45 companies over the last 7 years, with an average of 2 new investments annually in the last 5 years. In 2025, it made 3 investments, while as of Feb 2026, it has made 1 investment in this year. Its most recent first time investment was in PolyGone and most recent follow-on round was in Exero Medical.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 0 | 1 |
2025 | 2 | 1 | 3 |
2024 | 2 | 1 | 3 |
2023 | 2 | 0 | 2 |
2022 | 1 | 0 | 1 |
2021 | 2 | 1 | 3 |
2020 | 2 | 0 | 2 |
2019 | 1 | 0 | 1 |
Tech Council Ventures' Investments by Stage
Tech Council Ventures has made 7 investments in Series A stage with an average round size of $9.51M, 5 investments in Seed stage with an average round size of $2.5M and 1 investment in Grant (prize money) stage with an average round size of $2.7M.Stage of entry | No. of Investments |
|---|---|
Series A | 7 |
Seed | 5 |
Grant (prize money) | 1 |
Note: We have considered here, only first round of investments
Tech Council Ventures' Investments by Sector
Tech Council Ventures has a diverse portfolio, with companies operating in the Enterprise Applications, Chemicals and Materials, HealthTech, Life Sciences and Business Services. Notably, it has invested in 30 Enterprise (B2B) companies, 30 Tech companies, 15 Software companies and at least 9 companies focusing on Saas.Sector | No. of Investments |
|---|---|
Enterprise Applications | 4 |
Chemicals and Materials | 2 |
HealthTech | 2 |
Life Sciences | 2 |
Business Services | 1 |
Others | 10 |
Note: We have considered here, only first round of investments
Tech Council Ventures' Investments by Geography
Tech Council Ventures has made most investments in United States (12), followed by Israel where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 12 |
Israel | 1 |
Note: We have considered here, only first round of investments
Tech Council Ventures' recent investments
Tech Council Ventures has made 1 investments in 2026 so far - PolyGone.Here are the most recent investments by Tech Council Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Feb 19, 2026 | United States | Seed | 1261 | ||
Oct 30, 2025 | United States | Seed | 2491 | ||
Feb 13, 2025 | Israel | Grant (prize money) | 5245 | ||
Feb 13, 2025 | Israel | Seed | 9678 | ||
Jul 23, 2024 | United States | Series A | 8254 |
IPOs and Publicly Listed companies in Tech Council Ventures' Portfolio
1 of Tech Council Ventures' portfolio company became public - Cytosorbents. It got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jan 2013 at marketcap of undefinedHere are Tech Council Ventures' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jan 07, 2013 | - | - | 4640 |
Acquired companies in Tech Council Ventures' Portfolio
18 companies from Tech Council Ventures' portfolio have been acquired. The most recent acquisition were Nuance in Jan 2025 by HCL Technologies.Here are Tech Council Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jan 14, 2025 | - | - | 4194 | |
Jan 13, 2025 | - | - | 2338 | |
Nov 08, 2023 | - | - | 5512 | |
Mar 08, 2023 | - | - | 5216 | |
Sep 01, 2022 | Jan 08, 2019 | Series A | 7060 |
Team profile of Tech Council Ventures
Tech Council Ventures has a team of 7 members including 4 Partners located in United States. Tech Council Ventures' team sits on the board of 1 company.Here is a list of all team members in Tech Council Ventures:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Summit | - | ||
Partner | Trenton | - | ||
Partner | Bridgewater | - | - | |
Partner | United States | - |
Co-investors of Tech Council Ventures
Over the past 7 years, 74 investors have co-invested in Tech Council Ventures's portfolio companies. This includes funds and angels.
- Invested before Tech Council Ventures: New Jersey Economic Development Authority, Wistron and 15 others have invested in rounds before Tech Council Ventures. There are 2 companies where New Jersey Economic Development Authority has invested before Tech Council Ventures and 1 company where Wistron has invested before Tech Council Ventures.
- Top Co-investors of Tech Council Ventures: 43 investors entered a company along with Tech Council Ventures. These include investors like Boston Millennia Partners (2 companies).
- Invested after Tech Council Ventures: A total of 14 investors have invested in Tech Council Ventures's portfolio after their investments. Top Investors include HCAP Partners (1 company), HCAP (1 company) and Samsung Venture Investment (1 company).
Recent News related to Tech Council Ventures
•
PolyGone Systems Raises $4M Seed Round to Scale Microplastic Monitoring and RemovalBusiness Wire•Feb 19, 2026•PolyGone, Interstate Fusion Ventures, Tech Council Ventures, Golden Seeds and 1 other
•
•
•
•
Exero Medical scores $12.7M in funding and more digital funding newsMobiHealthNews•Feb 15, 2025•Exero Medical, Vitalchat, Cerula Care, Edge Medical Ventures and 2 others
•
•
•
•
Princeton NuEnergy Raises Additional $10.3M in Series A FundingFinSMEs•May 13, 2024•Princeton NuEnergy, SCG, Tech Council Ventures, LKQ
•
